Lemaitre Vascular (LMAT) FY2018 results: revenue $106 million, up 4.7% on the year
Lemaitre Vascular Inc. (LMAT) reported revenue of $106 million for fiscal 2018, the year ended 31 December 2018, up 4.7% on the year before. Net income was $23 million, up 33.6%, and diluted earnings per share $1.13. The figures are the company's own, from the 10-K it filed with the SEC on 11 March 2019.
Revenue
$106 million
+4.7% on the year
FY2011FY2018
Operating margin
26.7%
20.9% a year earlier
FY2011FY2018
Net income
$23 million
+33.6% on the year
FY2011FY2018
Diluted EPS
$1.13
+31.4% on the year
FY2011FY2018
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Revenue
106
101
89.2
+4.7%
Cost of revenue
31.6
30.2
26.2
+4.8%
Gross profit
73.9
70.7
62.9
+4.6%
Gross margin
70.0%
70.1%
70.6%
Research and development
8.2
6.6
6.1
+23.5%
Operating income
28.2
21.1
16.3
+33.7%
Operating margin
26.7%
20.9%
18.3%
Interest expense
0.0
0.0
0.0
-90.5%
Pre-tax income
28.4
21.1
16.2
+34.8%
Income tax
5.5
3.9
5.7
+40.0%
Effective tax rate
19.3%
18.6%
34.8%
Net income
22.9
17.2
10.6
+33.6%
Net margin
21.7%
17.0%
11.9%
Diluted EPS
$1.13
$0.86
$0.55
+31.4%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Operating cash flow
19.5
22.9
16.9
-14.7%
Capital expenditure
3.1
6.4
2.8
-52.4%
Free cash flow
16.5
16.5
14.1
+0.0%
Free cash flow margin
15.6%
16.3%
15.8%
Cash from investing
-7.1
-29.0
-17.2
Cash from financing
-4.4
0.1
-2.6
Depreciation and amortisation
4.3
4.1
3.6
+6.6%
Share-based compensation
2.3
2.3
1.7
+4.1%
Buybacks
0.7
0.8
0.3
-4.8%
Dividends paid
5.4
4.2
3.3
+30.3%
Dividend per share
$0.28
$0.22
$0.18
+27.3%
Diluted shares, weighted
20m
20m
19m
+1.0%
Balance sheet
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Shareholders' equity
130
110
87.5
+18.6%
Debt
0.0
0.0
0.0
Other liabilities
22.9
16.6
14.4
+38.1%
Total liabilities and equity
153
126
102
+21.2%
Fixed assets
14.1
12.4
8.0
+13.9%
Goodwill
29.9
23.8
23.4
+25.3%
Intangible assets
13.7
8.2
9.9
+66.3%
Investments
21.7
22.6
n/a
-4.0%
Cash and equivalents
26.3
19.1
24.3
+37.8%
Receivables
15.7
15.0
13.2
+4.8%
Inventory
n/a
n/a
19.6
Other assets
31.7
25.2
3.5
+25.8%
Total assets
153
126
102
+21.2%
10-K for the year ended 31 December 2018, filed 11 March 2019: the filing.